Knowledge Gaps in How to Manage Anaphylaxis, Epinephrine Use, Persist for Patients, Even EMS
ACAAI 2024. Two studies here showed that anaphylaxis protocols for EMS are outdated in many states and that many patients don't know how to use epinephrine.
GLP-1RAs Reduce Suicide Risk in Youth with Obesity: Daily Dose
Your daily dose of the clinical news you may have missed.
Survey Reveals Patient Concerns Over Colonoscopy Prep, Barriers to Procedure
More than half of US adults who had a colonoscopy in past 5 years said they wish they knew more information before their first procedure.
Monotherapy with Rifaximin vs Lactulose More Effective for Reducing Recurrence of Overt Hepatic Encephalopathy: New Post Hoc Analysis
Rifaximin monotherapy may also confer a survival benefit, according to the study, which was awarded ACG Outstanding Research Award in the Liver Category.
A Melanoma Diagnosis is a 3-Part Process, Dermatologist Rebecca Hartman, MD, MPH, Explains
A rapid increase in the rate of melanoma diagnoses could be the result of multiple factors, explains the Harvard assistant professor of dermatology.
FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
Oral sulopenem is the first oral penem approved in the US for treating uUTIs in women with limited options.
New Data on Needle Free Epinephrine Spray Presented at ACAAI 2024
A summary of new data presented at the 2024 American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Dupilumab Efficacy for Severe Atopic Dermatitis Durable at 5 Years: New Data
After 60 months of treatment, 38% of study participants with severe AD achieved complete remission.
Semaglutide Linked with Reduced Risk of Alzheimer Disease in Large Observational Study
Semaglutide significantly reduced risk of a first-time diagnosis of AD in a cohort of more than 1 million, suggesting an opportunity for controlled clinical trials.
New Drug Boosts COPD Lung Function, QoL Regardless of Severity: Daily Dose
Primary Care Assessment of Suspicious Skin Lesions: A Dermatologist Highlights DermaSensor
A bothersome skin lesion is typically first seen and assessed in primary care. An AI-based point-of-care device may help enhance triage, says Rebecca Hartman, MD, MPH.
ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals
CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.
Drug Duo Improves COVID-19 Outcomes: Daily Dose
CDC ACIP Meeting October 23-24: Day 1 Recap for Vaccines
The ACIP voted on recommendations for monovalent SARS-CoV-2 vaccine booster shots, lowering the age for pneumonia vaccination, and next steps for clesrovimab for RSV.
ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 from 65 Years
The expanded recommendation includes shots from Merck (PCV21) and Pfizer (PCV20), and could be a "practice-changing milestone," one executive said.
New Data on Renal Protective Benefits of Sotagliflozin Will be Presented at Kidney Week 2024
In a post hoc analysis of the SCORED trial, investigators observed positive renal protection with sotagliflozin across a spectrum of baseline kidney function and glycemic control.
Effects of Common Analgesic Medications on Sleep: A Topical Review
Findings from a recent review highlight the impact of common analgesic medications on sleep patterns in people with chronic pain.
Make Early Alzheimer Disease Medications Accessible to All, Now
FDA-approved early Alzheimer medications should be covered by Medicare and other insurers and made immediately available to all those who will benefit.
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions
Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.
COVID-19 Raises Risk of MACE up to 3 Years Later: Daily Dose
